Trials / Completed
CompletedNCT04452513
A Prospective Clinical Study of Phenylketonuria (PKU)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 32 (actual)
- Sponsor
- BioMarin Pharmaceutical · Industry
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
This is a study for adults and children ≥ 14 years old who have Phenylketonuria (PKU) with uncontrolled plasma Phe levels. No clinical intervention or study drug is provided by BioMarin in this study.
Conditions
Timeline
- Start date
- 2019-10-11
- Primary completion
- 2022-06-02
- Completion
- 2022-06-02
- First posted
- 2020-06-30
- Last updated
- 2023-03-14
Locations
14 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04452513. Inclusion in this directory is not an endorsement.